Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 13.80% vs -15.97% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 105.54% vs -552.52% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "168.20",
          "val2": "147.80",
          "chgp": "13.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.50",
          "val2": "-117.80",
          "chgp": "97.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.20",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8.60",
          "val2": "-155.30",
          "chgp": "105.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-15.00%",
          "val2": "-933.90%",
          "chgp": "91.89%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -3.45% vs -18.32% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -499.77% vs -64.27% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "739.10",
          "val2": "765.50",
          "chgp": "-3.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-90.80",
          "val2": "80.80",
          "chgp": "-212.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "0.70",
          "chgp": "14.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-4.30",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-171.10",
          "val2": "42.80",
          "chgp": "-499.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-238.20%",
          "val2": "-10.90%",
          "chgp": "-22.73%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

168.20

147.80

13.80%

Operating Profit (PBDIT) excl Other Income

-2.50

-117.80

97.88%

Interest

0.10

0.20

-50.00%

Exceptional Items

0.00

0.00

Consolidate Net Profit

8.60

-155.30

105.54%

Operating Profit Margin (Excl OI)

-15.00%

-933.90%

91.89%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 13.80% vs -15.97% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 105.54% vs -552.52% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

739.10

765.50

-3.45%

Operating Profit (PBDIT) excl Other Income

-90.80

80.80

-212.38%

Interest

0.80

0.70

14.29%

Exceptional Items

0.00

-4.30

100.00%

Consolidate Net Profit

-171.10

42.80

-499.77%

Operating Profit Margin (Excl OI)

-238.20%

-10.90%

-22.73%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -3.45% vs -18.32% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -499.77% vs -64.27% in Dec 2024

All Annual Results